Featured article
Aberrant Cytokine Activity in the Host Immune Response to COVID‑19 Leads to Cytokine Release Syndrome
Since the first cases of COVID-19 were identified in December 2019, the disease has spread across the world, claiming over half a million lives and affecting millions of others. Medical reports emerging from the pandemic illustrate a broad range of patient symptoms due to the host immune response, with evidence increasingly suggesting that cytokine release syndrome (CRS) may be responsible for the more severe complications of COVID-19.
Download this article to discover why the potential link between CRS and COVID‑19‑related deaths warrants further investigation, with details on:
- The mechanisms underlying CRS
- Supporting studies
- The tools used to examine the role of CRS
Fill out the form to access the featured article
Thank you for your interest!
Your file is ready: Aberrant Cytokine Activity in the Host Immune Response to COVID-19 Leads to Cytokine Release Syndrome
Download NowFeatured Webinars
Bio-Plex Readers and Technology
Bio-Plex Assays, Kits, and Reagents
Bio-Plex Multiplex Immunoassays allow you to simultaneously quantify up to 500 proteins, peptides, and nucleic acid targets in a single 12.5 µl sample. Assays for over 450 biologically relevant targets are available as ready-to-use premixed multiplex panels and singleplex sets or in custom-mixed panels. Custom assays can also be developed for new targets.
Find out More